101 related articles for article (PubMed ID: 27574743)
21. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
[No Abstract] [Full Text] [Related]
22. Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care.
Bieszk N; Grabner M; Wei W; Barron J; Quimbo R; Yan T; Biel B; Chu JW
J Manag Care Spec Pharm; 2017 Nov; 23(11):1160-1168. PubMed ID: 29083969
[TBL] [Abstract][Full Text] [Related]
23. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
24. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
25. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
[TBL] [Abstract][Full Text] [Related]
26. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.
Stuart B; Yin X; Davidoff A; Simoni-Wastila L; Zuckerman I; Shoemaker JS; Doshi J
Med Care; 2012 Nov; 50(11):913-9. PubMed ID: 23047779
[TBL] [Abstract][Full Text] [Related]
27. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
[TBL] [Abstract][Full Text] [Related]
28. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
[TBL] [Abstract][Full Text] [Related]
29. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
[TBL] [Abstract][Full Text] [Related]
30. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
[TBL] [Abstract][Full Text] [Related]
31. Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments.
Wei W; Jiang J; Lou Y; Ganguli S; Matusik MS
J Manag Care Spec Pharm; 2017 Mar; 23(3):278-290. PubMed ID: 28230445
[TBL] [Abstract][Full Text] [Related]
32. Effect of the ExactCare medication care management model on adherence, health care utilization, and costs.
Shetty KD; Chen AY; Rose AJ; Liu HH
J Manag Care Spec Pharm; 2021 May; 27(5):574-585. PubMed ID: 33560167
[No Abstract] [Full Text] [Related]
33. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
Kale HP; Patel AM; Carroll NV
J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
[No Abstract] [Full Text] [Related]
36. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
[No Abstract] [Full Text] [Related]
37. Is the Currently Used Prescription Adjudication Date a Good Proxy for Calculating Medication Refill Adherence?
Lester CA; Look KA; Chui MA
J Manag Care Spec Pharm; 2016 Nov; 22(11):1311-1317. PubMed ID: 27783554
[TBL] [Abstract][Full Text] [Related]
38. Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder.
Perk S; Wielage RC; Campbell NL; Klein TM; Perkins A; Posta LM; Yuran T; Klein RW; Ng DB
J Manag Care Spec Pharm; 2016 Sep; 22(9):1072-84. PubMed ID: 27579830
[TBL] [Abstract][Full Text] [Related]
39. Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part D.
Spencer SH; Suda KJ; Smith BM; Huo Z; Bailey L; Stroupe KT
J Manag Care Spec Pharm; 2016 Jul; 22(7):818-24. PubMed ID: 27348283
[TBL] [Abstract][Full Text] [Related]
40. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
